Moreover, another study highlighted that the deletion of RBP-J in cardiomyocytes brought about increased hypoxia tolerance and improved cardiac function after MI (21), underscoring inhibition of RBP-J as a potential treatment strategy against ischemic injury. Here, RBPJ is linked to myocardial infarction.